MRPS18B and prostate carcinoma: The same study also found that increased expression of MRPS18B improved the migratory ability of prostate cancer cells through the induction of EMT, via chemokine signalling (CXCL12-CXCR4), and increased EMT transcription factor (TWIST2) expression [29].